Page-3 of COVID-19 vaccine Current Affairs, GK & News

J&J’s single-dose vaccine approved for emergency use in India

Johnson and Johnson’s single-dose COVID-19 vaccine approved for emergency use India. With this vaccine, India has five Emergency Use Authorization vaccines. This move will further boost India’s collective fight against COVID-19. Johnson & Johnson COVID-19 vaccine This vaccine, also called as Janssen COVID-19 vaccine, has been developed by Janssen Vaccines in Leiden, Netherlands. Its Belgian ..

Month: 

Category: 

Topics: 

UAE launches Covid vaccine for children aged 3-17

United Arab Emirates (UAE) launched Covid-19 vaccines for children aged 3 to 17. Key Points UAE will administer China’s Sinopharm COVID-19 vaccine to children aged 3-17. This decision was taken after clinical trials and extensive evaluations. As per authorities, trial was monitored for immune response of 900 children. UAE is among world’s highest immunisation rates. ..

Month: 

Category: 

Topics: 

IISc-Mynvax’s heat-tolerant Covid vaccine

Indian Institute of Science (IISc) Bengaluru has developed a heat-tolerant COVID-19 vaccine formulation. While studying on animals, it was found to be effective against all current SARS-CoV-2 variants of concern. Key Points Research was published in ACS Infectious Diseases journal. This vaccine was formulated by IISc-incubated biotech start-up Mynvax, built a strong immune response in ..

Month: 

Category: 

Topics: 

Ladakh: 1st UT to achieve 100% first dose coverage

Ladakh has become first Union Territory to vaccinate all residents and guest population; comprising of migrant labourers, hotel workers and Nepalese citizens earning their livelihood in the territory; with first dose of Covid-19 jab. Key Points In spite of Ladakh’s low population, this is no mean feat because of region’s challenging terrain, extreme weather and ..

Month: 

Category: 

Topics: 

Cuba develops world’s first conjugate Covid-19 vaccine

Cuba has developed world’s first conjugate Covid-19 vaccine Soberana 2 (Sovereign 2). Highlights When the Soberana 2 vaccine is delivered with booster shot of Soberana Plus, it is 91 percent effective against symptomatic Covid-19 cases. If this vaccine is approved, Cuba will become first Latin American country to manufacture and produce vaccine against Covid-19. How ..

Month: 

Category: 

Topics: